AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2021
Mar 8, 2021
35038_dirs_2021-03-08_366ac3b6-5ae7-42b5-8a78-686fc84349d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2021-03-04
Reporting Person: Kosacz Barbara (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are benefically owned. | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| No securities are benefically owned. | $0.00 | Not applicable (0) | Direct |
Footnotes
F1: Not applicable.
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Capital/Financing Update
2026
Apr 1
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Board/Management Information
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Capital/Financing Update
2026
Jan 20
Capital/Financing Update
2026
Jan 20